Onikepe Adegbola MD PhD
Nuclear Medicine
Chief Medical Officer, Molecular Imaging Executive Medical Director - GE Healthcare
Join to View Full Profile
3400 Spruce St1 Maloney BuildingPhiladelphia, PA 19104
Phone+1 215-662-3957
Dr. Adegbola is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Cornell University – Johnson Graduate School Of ManagementExecutive Education, 2013 - 2013
University of Pennsylvania Health SystemFellowship, Nuclear Medicine, 2005 - 2007- The Johns Hopkins University School Of MedicinePhD, Pathobiology; Concentration in Cancer Biology, 2005 - 2005
University of California, San FranciscoPost-Doctoral Fellowship, 2000 - 2001
New York Presbyterian Hospital (Columbia Campus)Residency, Pathology-Anatomic and Clinical, 1998 - 2000
Howard UniversityInternship, Transitional Year, 1997 - 1998
University of Lagos College of MedicineClass of 1995
Certifications & Licensure
PA State Medical License 2009 - 2026
CT State Medical License 2007 - 2025
Awards, Honors, & Recognition
- UNCF Merck Fellowship 2004
- Honorable Mention, L’Oreal Women in Science Fellowship 2004
- Johns Hopkins Department of Pathology Young Investigator Day award 2003, 2004, 2004
- Join now to see all
Publications & Presentations
PubMed
- 27 citationsIn vivo MRS markers of response to CHOP chemotherapy in the WSU-DLCL2 human diffuse large B-cell lymphoma xenograft.Seung-Cheol Lee, Ming Q. Huang, David Nelson, Stephen Pickup, Suzanne Wehrli
NMR in Biomedicine. 2008-08-01 - 5 citationsHepatobiliary scintigraphy monitoring patency of partial external biliary diversion in a patient with progressive familial intrahepatic cholestasis.Onikepe Adegbola, Hua Yang, Hongming Zhuang
Clinical Nuclear Medicine. 2006-10-01 - 11 citationsA pp32-retinoblastoma protein complex modulates androgen receptor-mediated transcription and associates with components of the splicing machinery.Onikepe Adegbola, Gary R. Pasternack
Biochemical and Biophysical Research Communications. 2005-08-26
Journal Articles
- Molecular Imaging in Clinical Trials.Adegbola, O., and Conti, P., Springer
Abstracts/Posters
- Comparability of quantitative SUV measurement between PET alone and PET-CT on patients scanned consecutively on PET and PET-CT scanners.M. Bathaii, J.R. Saffer, P.H. Tang, J. Karp, O. Adegbola, L. Loevner, A. Alavi, SNM meeting
- A pp32 - Rb complex modulates androgen receptor-dependent transcription and associates with components of the splicing machinery.Adegbola, O., Pasternack, G.R., Biochem Biophys Res Commun; 334(2):702-8
Lectures
- Enhancing Imaging Techniques and Technologies to Streamline Drug Development.Translational Imaging in Drug Development, London, UK
- Strategies to Facilitate Translational Imaging in Drug Development.2nd Imaging in Drug Development, London, UK
- Exploratory Imaging in Drug Development - Cost Analysis and Resource Requirements.Annual Medical Imaging for Clinical Trials, Arlington, VA
- Join now to see all
Other
- Control of proliferation and apoptosis in cancer cells.Pasternack, G.R., Adegbola, O. and The Johns Hopkins University School of Medicine, U.S. Provisional 11/413,082
- Annotation of the Genome of Candida albicans.Dungan J, Kuo A, Newport G, Lan C-Y, Iijima,C, Adegbola O, Roberts J, Persson K, Donnelly S, Favoreto S, Tzung K-W, Jones T, Scherer S. and Agabian N, Update to the NCBI Entrez Nucleotide Accession AACQ00000000
http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=AACQ00000000
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
